Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filipa Lynce

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
Cancer|June 22, 2021
Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancerFilipa Lynce, Matthew J Blackburn, Rebecca Zhuo, et al.
Cancer Immunology Research|October 15, 2024
T Cells Instruct Immune Checkpoint Inhibitor Therapy Resistance in Tumors Responsive to IL1 and TNFα InflammationNam Woo Cho, Sophia M Guldberg, Barzin Y Nabet, et al.
NPJ Breast Cancer|September 26, 2017
Video intervention increases participation of black breast cancer patients in therapeutic trialsBrandi N Robinson, Antoinette F Newman, Eshetu Tefera, et al.
Breast Cancer Research and Treatment|January 5, 2021
Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with breast cancer and compromised heart functionKatia Khoury, Filipa Lynce, Ana Barac, et al.
Breast Cancer Research and Treatment|September 20, 2022
Molecular characterization of ESR1 variants in breast cancerArielle L Heeke, Andrew Elliott, Rebecca Feldman, et al.
Cancer|August 30, 2024
Generative artificial intelligence as a source of breast cancer information for patients: Proceed with cautionKo Un Park, Stuart Lipsitz, Laura S Dominici, et al.
NPJ Breast Cancer|June 2, 2023
Clinical outcomes of de novo metastatic HER2-positive inflammatory breast cancerAna C Garrido-Castro, Meredith M Regan, Samuel M Niman, et al.
NPJ Breast Cancer|April 16, 2024
Clinicopathological characteristics and eligibility for adjuvant olaparib of germline BRCA1/2 mutation carriers with HER2-negative early breast cancerStefania Morganti, Qingchun Jin, Julie Vincuilla, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2022
HER2-low inflammatory breast cancer: Clinicopathologic features and prognostic implicationsPaolo Tarantino, Samuel M Niman, Timothy K Erick, et al.
Cancer Research|March 20, 2024
A Subpopulation of Luminal Progenitors Secretes Pleiotrophin to Promote Angiogenesis and Metastasis in Inflammatory Breast CancerMengmeng Zhang, Kaiwen Zhou, Zilin Wang, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
Cancer|June 22, 2021
Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancerFilipa Lynce, Matthew J Blackburn, Rebecca Zhuo, et al.
Cancer Immunology Research|October 15, 2024
T Cells Instruct Immune Checkpoint Inhibitor Therapy Resistance in Tumors Responsive to IL1 and TNFα InflammationNam Woo Cho, Sophia M Guldberg, Barzin Y Nabet, et al.
NPJ Breast Cancer|September 26, 2017
Video intervention increases participation of black breast cancer patients in therapeutic trialsBrandi N Robinson, Antoinette F Newman, Eshetu Tefera, et al.
Breast Cancer Research and Treatment|January 5, 2021
Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with breast cancer and compromised heart functionKatia Khoury, Filipa Lynce, Ana Barac, et al.
Breast Cancer Research and Treatment|September 20, 2022
Molecular characterization of ESR1 variants in breast cancerArielle L Heeke, Andrew Elliott, Rebecca Feldman, et al.
Cancer|August 30, 2024
Generative artificial intelligence as a source of breast cancer information for patients: Proceed with cautionKo Un Park, Stuart Lipsitz, Laura S Dominici, et al.
NPJ Breast Cancer|June 2, 2023
Clinical outcomes of de novo metastatic HER2-positive inflammatory breast cancerAna C Garrido-Castro, Meredith M Regan, Samuel M Niman, et al.
NPJ Breast Cancer|April 16, 2024
Clinicopathological characteristics and eligibility for adjuvant olaparib of germline BRCA1/2 mutation carriers with HER2-negative early breast cancerStefania Morganti, Qingchun Jin, Julie Vincuilla, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2022
HER2-low inflammatory breast cancer: Clinicopathologic features and prognostic implicationsPaolo Tarantino, Samuel M Niman, Timothy K Erick, et al.
Cancer Research|March 20, 2024
A Subpopulation of Luminal Progenitors Secretes Pleiotrophin to Promote Angiogenesis and Metastasis in Inflammatory Breast CancerMengmeng Zhang, Kaiwen Zhou, Zilin Wang, et al.
Pageof 10